In a recent publication, we noticed that urinary complement components C9, C4b, and CFB might be used as biomarkers for severe FSGS with steroid-resistant nephrotic syndrome, progressing the disease with the formation of TIF [15]. The gene discussed is C9; the disease is focal segmental glomerulosclerosis.